Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anke Biotechnology, officially known as Anhui Anke Biotechnology (Group) Co., Ltd., is a leading Chinese biopharmaceutical company headquartered in Hefei. The company specializes in the research, development, and commercialization of recombinant DNA products, including human growth hormone (Ansomone) and interferon alpha-2b (Anferon). Beyond its core protein therapeutics, Anke has expanded into precision medicine, oncology, and cell therapy, including CAR-T developments through its subsidiaries. It operates as a fully integrated enterprise with robust manufacturing capabilities and a significant presence in both domestic and international markets. The company is publicly traded on the Shenzhen Stock Exchange and is a cornerstone of the Hefei high-tech biotech cluster.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hefei companies.